223Ra in asymptomatic patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) who progressed to first-line abiraterone acetate or enzalutamide
No Thumbnail Available
Identifiers
Date
2020-09-01
Authors
Carles, J.
Alonso, T.
Mellado Gonzalez, B.
Mendez Vidal, M. J.
Vazquez Estevez, S.
Gonzalez del Alba, A.
Piulats, J. M.
Borrega Garcia, P.
Gallardo, E.
Morales Barrera, R.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
